Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)

• Published in: Journal of ovarian research 2019-05, Vol.12 (1), p.50-50, Article 50
• Main Authors: Stanciu, P I, Ind, T E J, Barton, D P J, Butler, J B, Vroobel, K M, Attygalle, A D, Nobbenhuis, M A E
• Format: Article
• Language: English
• Subjects: BRCA; BRCA mutations; Breast cancer; Cancer; Carcinoma; Care and treatment; Complications and side effects; Fallopian tube diseases; Family medical history; Female genital cancer; Gastric cancer; Health risk assessment; Mortality; Mutation; Oophorectomy; Ovarian cancer; Ovarian carcinoma; Ovariectomy; p53 Protein; Patient outcomes; Patients; Peritoneal carcinoma; Peritoneal diseases; Peritoneum; Risk factors; Risk-reducing Salpingo-oophorectomy; Salpingo-oophorectomy; Serous tubal intraepithelial carcinoma; Surgery; Tumor proteins; Women; Womens health
• ISSN: 1757-2215; 1757-2215
• DOI: 10.1186/s13048-019-0525-1

The management of Serous Tubal Intraepithelial Carcinoma (STIC) found at the time of Risk-Reducing Salpingo-Oophorectomy (RRSO) remains unclear. We set out to analyse the incidence of peritoneal carcinomas developed after prophylactic surgery and to formulate further guidance for these patients. This is a retrospective study of 300 consecutive RRSO performed at the Royal Marsden Hospital between January 2008 and January 2017. The median age at RRSO was 47.8 years (range 34 to 60 years) and median BMI was 26.2 kg/m (range 16 to 51 kg/m ). A total of 273 patients (91%) were tested for BRCA mutations. Of these, 124 (45.4%) had a BRCA 1 mutation, 118 (43.2%) had a BRCA 2 mutation, 2 (0.7%) had both a BRCA 1 and a BRCA 2 mutation and 29 (10.6%) had no BRCA mutation detected. Isolated STIC lesions were identified in 7 cases (2.3%) and p53 signatures in 75 cases (25%). There were five (1.6%) incidental tubal carcinomas and one (0.3%) ovarian carcinoma at the time of surgery. Two (28.6%) of the 7 patients with STIC identified following RRSO had high grade serous peritoneal carcinoma diagnosed at 53 and 75 months. One (0.3%) patient from the other 287 patients from our series with no STIC diagnosis or incidental carcinomas at RRSO developed high grade serous carcinoma of peritoneal origin after 92 months. This study demonstrates that when a STIC lesion is identified following RRSO there is a significantly higher risk of a subsequent peritoneal cancer. Although there is no published consensus in literature, we recommend that consideration should be given for long term follow-up if a STIC lesion is identified at RRSO.